Citadel Advisors
TTOO

Citadel Advisors’s T2 Biosystems, Inc TTOO Stock Holding History

Citadel Advisors’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-18
Closed -$398 – 15521
2023
Q3 		$398 Sell
18
-156
-90% -$4.07K ﹤0.01% 14067
2023
Q2 		$1.23K Buy
174
+12
+7% +$276 ﹤0.01% 13960
2023
Q1 		$7.45K Buy
+162
New +$17.7K ﹤0.01% 13719
2022
Q4 		– Sell
-12
Closed -$7K – 15629
2022
Q3 		$7K Hold
12
– – ﹤0.01% 12334
2022
Q2 		$10K Sell
12
-2
-14% -$2.96K ﹤0.01% 12586
2022
Q1 		$37K Sell
14
-11
-44% -$23.4K ﹤0.01% 12992
2021
Q4 		$64K Sell
25
-2
-7% -$6.96K ﹤0.01% 13099
2021
Q3 		$122K Sell
27
-7
-21% -$35.2K ﹤0.01% 12626
2021
Q2 		$202K Sell
34
-17
-33% -$110K ﹤0.01% 12144
2021
Q1 		$413K Buy
51
+42
+467% +$445K ﹤0.01% 10103
2020
Q4 		$56K Sell
9
-13
-59% -$79.6K ﹤0.01% 10531
2020
Q3 		$150K Buy
22
+2
+10% +$14.8K ﹤0.01% 9006
2020
Q2 		$125K Buy
20
+12
+150% +$51K ﹤0.01% 8867
2020
Q1 		$26K Buy
8
+5
+167% +$20.8K ﹤0.01% 9233
2019
Q4 		$15K Buy
+3
New +$28.4K ﹤0.01% 8978
2019
Q3 		– Sell
-3
Closed -$26K – 9893
2019
Q2 		$26K Hold
3
– – ﹤0.01% 8905
2019
Q1 		$36K Buy
+3
New +$51K ﹤0.01% 8945

Other funds holding TTOO

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Citadel Advisors's TTOO Position: Q4 2023 in Review

Citadel Advisors sold out of T2 Biosystems, Inc (TTOO) in Q4 2023, closing a stake of 10 shares — an estimated $221 sold.

Citadel Advisors first reported a position in TTOO in Q4 2015 and held it in 18 quarters. The position peaked at $434K in Q1 2021. 21 funds tracked by Wall St. Rank hold TTOO as of Q4 2023.

  • Citadel Advisors reported no remaining T2 Biosystems, Inc position as of Q4 2023 after selling out during the quarter.
  • Citadel Advisors sold 10 T2 Biosystems, Inc shares in Q4 2023, an estimated $221.
  • Citadel Advisors first reported a position in T2 Biosystems, Inc in Q4 2015 and held it in 18 quarters.
  • Citadel Advisors's T2 Biosystems, Inc position peaked at $434K in Q1 2021.
  • 21 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2023.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.